|
⚲
|
| Keyboard |
| Gruskin Daniel
✚
|
|
|---|---|
| CIK # | 0001863053 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001863053] | |
| 4 | [0001863053] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| LogicBio Therapeutics Inc | |
| Gruskin Daniel |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
LogicBio Therapeutics Inc LOGC
Common Stock
|
2022-11-16 | Disposed to issuer | 3,331 | ||
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2022-11-16 | Disposed to issuer | 140,000 | ||
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2022-03-01 | Grant | 140,000 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Common Stock
|
2021-08-09 | Sell | 1,467 | $4.35 | 6,381 |
|
LogicBio Therapeutics Inc LOGC
Common Stock
|
2021-08-06 | Option exercise | 4,798 | ||
|
LogicBio Therapeutics Inc LOGC
Restricted Stock Units · derivative
|
2021-08-06 | Option exercise | 4,798 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Employee Stock Option (Right to buy) · derivative
|
2021-05-19 | Grant | 60,000 | $0.00 |